Biopticon Corporation, based in Princeton, NJ, is a leading company in the field of tumor management systems. Their flagship product, the TumorImager 2, is a fast and accurate 3D scanning device for measuring subcutaneous tumors on small animals, offering real color images and the flexibility of handheld or hands-free scanning.
In addition to the TumorImager 2, Biopticon also provides the TumorManager software, a comprehensive program for managing pre-clinical oncology studies, from protocol design to statistical analysis and final reporting. With a commitment to specialized support, Biopticon offers assistance for all aspects of their Tumor Management System, ensuring customers receive the help they need for simple usage questions or complex technical issues.
Generated from the website